| Innovation Title | Categories | Lead Inventor | |
|---|---|---|---|
|
Novel inhalation formulations of polymyxins
2020-ZHOU-68990 |
Zhou, Qi | ||
|
Composites with Ivacaftor and Colistin for Cystic Fibrosis and Bacterial Lung Infection Treatment
2020-ZHOU-68954 |
Zhou, Qi | ||
|
Combination Pharmaceutical Formulations
2018-ZHOU-68184 |
Zhou, Qi | ||
|
Novel Inhalation Formulation of Antimicrobials
2018-ZHOU-68233 |
Zhou, Qi | ||
|
Liposomal Formulation of Combinational Antibiotics
2018-ZHOU-68205 |
Zhou, Qi | ||
|
Dr. Qi (Tony) Zhou is an Associate Professor in the Department of Industrial and Physical Pharmacy of Purdue University. He has published over 60 journal articles and secured over $4M in research funding from government as well as industry such as NIH R01 and Bill & Melinda Gates Foundation grants. His research is focused on pharmaceutical formulation and manufacturing. Dr. Zhou's contributions to the field of pharmaceutical sciences have been recognized with many awards including a 2015 AAPS Postdoctoral Fellowship, 2016 IPEC Excipient Emerging Researcher Award, and 2017 New Investigator Award in Aerosol Medicine. Dr. Zhou is an Editor of AAPS PharmSciTech, Editorial Board Member of the Journal of Pharmaceuticals Sciences, and current Pharmaceutical Design and Drug Development researcher of Industrial Pharmacy at Purdue University. For more information on Qi Zhou, please visit his Purdue webpage: https://www.ipph.purdue.edu/faculty/zhou659 or his research page: https://www.researchgate.net/profile/Qi_Zhou13 |
|
|
